USD
+$0.00
(+0.00%
)At Close (As of Sep 12, 2025)
$720.16M
Market Cap
12.89
P/E Ratio
1.05
EPS
$32.97
52 Week High
$10.96
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $224M |
Total Revenue | $334M |
Cost Of Revenue | $110M |
Costof Goods And Services Sold | $110M |
Operating Income | $41M |
Selling General And Administrative | $124M |
Research And Development | $72M |
Operating Expenses | $183M |
Investment Income Net | - |
Net Interest Income | $12M |
Interest Income | $12M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $20M |
Income Before Tax | $53M |
Income Tax Expense | $310K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $53M |
Comprehensive Income Net Of Tax | - |
Ebit | -$54M |
Ebitda | -$34M |
Net Income | $53M |
Field | Value (USD) |
---|---|
Total Assets | $491M |
Total Current Assets | $352M |
Cash And Cash Equivalents At Carrying Value | $115M |
Cash And Short Term Investments | $115M |
Inventory | $20M |
Current Net Receivables | $65M |
Total Non Current Assets | $139M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $38M |
Intangible Assets Excluding Goodwill | $38M |
Goodwill | $40M |
Investments | - |
Long Term Investments | - |
Short Term Investments | $146M |
Other Current Assets | $7.1M |
Other Non Current Assets | - |
Total Liabilities | $113M |
Total Current Liabilities | $89M |
Current Accounts Payable | $7.7M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $6.1M |
Total Non Current Liabilities | $23M |
Capital Lease Obligations | $28M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $28M |
Other Current Liabilities | $82M |
Other Non Current Liabilities | $819K |
Total Shareholder Equity | $378M |
Treasury Stock | - |
Retained Earnings | -$626M |
Common Stock | $51K |
Common Stock Shares Outstanding | $57M |
Field | Value (USD) |
---|---|
Operating Cashflow | $38M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $20M |
Capital Expenditures | $6.5M |
Change In Receivables | - |
Change In Inventory | -$1M |
Profit Loss | - |
Cashflow From Investment | -$483K |
Cashflow From Financing | -$5.6M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$522K |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $53M |
Field | Value (USD) |
---|---|
Gross Profit | $224M |
Total Revenue | $334M |
Cost Of Revenue | $110M |
Costof Goods And Services Sold | $110M |
Operating Income | $41M |
Selling General And Administrative | $124M |
Research And Development | $72M |
Operating Expenses | $183M |
Investment Income Net | - |
Net Interest Income | $12M |
Interest Income | $12M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $20M |
Income Before Tax | $53M |
Income Tax Expense | $310K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $53M |
Comprehensive Income Net Of Tax | - |
Ebit | -$54M |
Ebitda | -$34M |
Net Income | $53M |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.